4FNL
Crystal structure of broadly neutralizing antibody C05
Summary for 4FNL
| Entry DOI | 10.2210/pdb4fnl/pdb |
| Related | 4FNK 4FP8 4FQR |
| EMDB information | 2138 2139 2140 |
| Descriptor | Antibody C05, Heavy Chain, Antibody C05, Light Chain, 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL, ... (4 entities in total) |
| Functional Keywords | immunoglobulin, immune recognition, immune system |
| Biological source | Homo sapiens (human) More |
| Total number of polymer chains | 4 |
| Total formula weight | 99462.70 |
| Authors | Ekiert, D.C.,Wilson, I.A. (deposition date: 2012-06-19, release date: 2012-09-19, Last modification date: 2024-10-30) |
| Primary citation | Ekiert, D.C.,Kashyap, A.K.,Steel, J.,Rubrum, A.,Bhabha, G.,Khayat, R.,Lee, J.H.,Dillon, M.A.,O'Neil, R.E.,Faynboym, A.M.,Horowitz, M.,Horowitz, L.,Ward, A.B.,Palese, P.,Webby, R.,Lerner, R.A.,Bhatt, R.R.,Wilson, I.A. Cross-neutralization of influenza A viruses mediated by a single antibody loop. Nature, 489:526-532, 2012 Cited by PubMed Abstract: Immune recognition of protein antigens relies on the combined interaction of multiple antibody loops, which provide a fairly large footprint and constrain the size and shape of protein surfaces that can be targeted. Single protein loops can mediate extremely high-affinity binding, but it is unclear whether such a mechanism is available to antibodies. Here we report the isolation and characterization of an antibody called C05, which neutralizes strains from multiple subtypes of influenza A virus, including H1, H2 and H3. X-ray and electron microscopy structures show that C05 recognizes conserved elements of the receptor-binding site on the haemagglutinin surface glycoprotein. Recognition of the haemagglutinin receptor-binding site is dominated by a single heavy-chain complementarity-determining region 3 loop, with minor contacts from heavy-chain complementarity-determining region 1, and is sufficient to achieve nanomolar binding with a minimal footprint. Thus, binding predominantly with a single loop can allow antibodies to target small, conserved functional sites on otherwise hypervariable antigens. PubMed: 22982990DOI: 10.1038/nature11414 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (2.297 Å) |
Structure validation
Download full validation report






